Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Intramuscular VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04913675
Recruitment Status : Active, not recruiting
First Posted : June 4, 2021
Last Update Posted : November 17, 2021
Information provided by (Responsible Party):
Vir Biotechnology, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : September 18, 2021
Estimated Study Completion Date : August 2022